CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
9.25
3.04%
Market Trading Hours* (UTC) Open now
Closes on Monday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.10
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023512 %
Charges from full value of position ($-4.47)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023512%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00129 %
Charges from full value of position ($0.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00129%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 9.54
Open 9.59
1-Year Change -59.21%
Day's Range 9.25 - 9.84
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 24, 2025 9.54 -0.43 -4.31% 9.97 10.03 9.52
Jan 23, 2025 10.16 0.39 3.99% 9.77 10.24 9.48
Jan 22, 2025 9.99 0.09 0.91% 9.90 10.16 9.39
Jan 21, 2025 9.67 0.75 8.41% 8.92 9.80 8.87
Jan 17, 2025 8.83 0.01 0.11% 8.82 9.13 8.65
Jan 16, 2025 8.80 0.23 2.68% 8.57 8.90 8.22
Jan 15, 2025 8.58 -0.19 -2.17% 8.77 9.10 8.17
Jan 14, 2025 8.54 -1.50 -14.94% 10.04 10.26 8.43
Jan 13, 2025 9.07 -0.06 -0.66% 9.13 9.89 8.88
Jan 10, 2025 9.35 -1.48 -13.67% 10.83 10.83 9.12
Jan 8, 2025 11.70 0.33 2.90% 11.37 11.71 11.33
Jan 7, 2025 11.74 0.01 0.09% 11.73 12.18 11.29
Jan 6, 2025 11.84 -0.17 -1.42% 12.01 12.35 11.68
Jan 3, 2025 12.01 1.53 14.60% 10.48 12.18 10.48
Jan 2, 2025 10.71 -0.04 -0.37% 10.75 11.10 10.63
Dec 31, 2024 10.58 0.10 0.95% 10.48 11.02 10.38
Dec 30, 2024 10.87 0.40 3.82% 10.47 11.02 10.47
Dec 27, 2024 11.00 0.15 1.38% 10.85 11.06 10.57
Dec 26, 2024 11.02 0.78 7.62% 10.24 11.18 10.20
Dec 24, 2024 10.49 0.08 0.77% 10.41 10.61 10.35

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Quanterix Company profile

About Quanterix Corp

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to reliably detect protein biomarkers at extremely low concentrations in blood, serum and other fluids. Its products include HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and 2470 Arrayer. It also supplies NF-Light antibodies and ELISA kits, which offer solutions for the detection of neurofilament light (Nf-L) for the development of therapeutics and diagnostics for neurodegenerative conditions. Its portfolio of available kits spans multiple therapeutic areas, including cardiology, infectious disease, inflammation, neurology, and oncology. It provides services through its Simoa Accelerator Laboratory.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Quanterix Corp revenues increased 28% to $110.6M. Net loss increased 83% to $57.7M. Revenues reflect Product revenue segment increase of 84% to $81.1M. Higher net loss reflects Selling, General & Administrative Expens increase of 55% to $79M (expense), Research & Development Expense - Balanci increase of 37% to $26.2M (expense).

Industry: Advanced Medical Equipment & Technology (NEC)

900 Middlesex Turnpike
BILLERICA
MASSACHUSETTS 01821
US

People also watch

Gold

2,743.73 Price
-1.040% 1D Chg, %
Long position overnight fee 0.0056%
Short position overnight fee -0.0139%
Overnight fee time 22:00 (UTC)
Spread 0.30

ETH/USD

3,142.63 Price
-4.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

XRP/USD

2.97 Price
-4.590% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01480

US100

21,231.00 Price
-2.720% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 22:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading